Table 1 Correlation factors between tumor volumes and average ratios of lymphocytes expressing CD107a, granzyme B or perforin in tumors from LLC1 or MC-38 tumor-bearing mice intraperitoneally dosed with anti-PD-1 antibody.
 |  | LLC1/tumors | MC-38/tumors | ||||
---|---|---|---|---|---|---|---|
CD107a+ | Granzyme B+ | Perforin+ | CD107a+ | Granzyme B+ | Perforin+ | ||
CD4+T cells | Isotype control | 0.555 | − 0.216 | − 0.760 | 0.822 | 0.436 | 0.350 |
Anti-PD-1 mAb | 0.075 | − 0.457 | 0.590 | 0.473 | − 0.975** | − 0.995** | |
CD8+T cells | Isotype control | 0.431 | − 0.199 | − 0.936* | 0.966** | 0.193 | 0.502 |
Anti-PD-1 mAb | 0.287 | 0.818 | 0.367 | − 0.484 | 0.419 | − 0.497 | |
Tregs | Isotype control | 0.768 | 0.829 | − 0.326 | 0.778 | 0.583 | 0.758 |
Anti-PD-1 mAb | − 0.554 | − 0.798 | 0.788 | 0.887* | 0.554 | − 0.464 | |
B cells | Isotype control | 0.865 | − 0.394 | − 0.401 | 0.956* | − 0.104 | − 0.202 |
Anti-PD-1 mAb | − 0.083 | 0.112 | − 0.868 | 0.930* | 0.315 | − 0.405 | |
NK cells | Isotype control | 0.499 | 0.584 | − 0.466 | 0.960** | 0.954* | 0.394 |
Anti-PD-1 mAb | 0.499 | − 0.135 | − 0.409 | 0.703 | − 0.486 | − 0.003 | |
NKT cells | Isotype control | 0.552 | − 0.016 | − 0.451 | 0.962** | 0.511 | 0.664 |
Anti-PD-1 mAb | − 0.500 | − 0.462 | 0.254 | 0.770 | − 0.224 | − 0.934* |